<?xml version='1.0' encoding='utf-8'?>
<document id="26123461"><sentence text="Reactivation of chronic hepatitis B during treatment with tenofovir disoproxil fumarate: drug interactions or low adherence?"><entity charOffset="58-87" id="DDI-PubMed.26123461.s1.e0" text="tenofovir disoproxil fumarate" /></sentence><sentence text="We describe a case of a 61-year-old man with chronic hepatitis B, hepatitis B e antibody (HBeAb) positive, treated with tenofovir disoproxil fumarate (TDF), who developed virological and biochemical viremic reactivation with an increase in transaminase plasma levels"><entity charOffset="120-149" id="DDI-PubMed.26123461.s2.e0" text="tenofovir disoproxil fumarate" /><entity charOffset="151-154" id="DDI-PubMed.26123461.s2.e1" text="TDF" /><pair ddi="false" e1="DDI-PubMed.26123461.s2.e0" e2="DDI-PubMed.26123461.s2.e0" /><pair ddi="false" e1="DDI-PubMed.26123461.s2.e0" e2="DDI-PubMed.26123461.s2.e1" /></sentence><sentence text=" The patient's history revealed that he had discontinued TDF about 5 days before admission and, from December 2013, had been taking venlafaxine, paroxetine and zolpidem for some episodes of depression"><entity charOffset="132-143" id="DDI-PubMed.26123461.s3.e0" text="venlafaxine" /><entity charOffset="145-155" id="DDI-PubMed.26123461.s3.e1" text="paroxetine" /><entity charOffset="160-168" id="DDI-PubMed.26123461.s3.e2" text="zolpidem" /><entity charOffset="57-64" id="DDI-PubMed.26123461.s3.e3" text="TDF" /><pair ddi="false" e1="DDI-PubMed.26123461.s3.e3" e2="DDI-PubMed.26123461.s3.e3" /><pair ddi="false" e1="DDI-PubMed.26123461.s3.e3" e2="DDI-PubMed.26123461.s3.e0" /><pair ddi="false" e1="DDI-PubMed.26123461.s3.e3" e2="DDI-PubMed.26123461.s3.e1" /><pair ddi="false" e1="DDI-PubMed.26123461.s3.e3" e2="DDI-PubMed.26123461.s3.e2" /><pair ddi="false" e1="DDI-PubMed.26123461.s3.e0" e2="DDI-PubMed.26123461.s3.e0" /><pair ddi="false" e1="DDI-PubMed.26123461.s3.e0" e2="DDI-PubMed.26123461.s3.e1" /><pair ddi="false" e1="DDI-PubMed.26123461.s3.e0" e2="DDI-PubMed.26123461.s3.e2" /><pair ddi="false" e1="DDI-PubMed.26123461.s3.e1" e2="DDI-PubMed.26123461.s3.e1" /><pair ddi="false" e1="DDI-PubMed.26123461.s3.e1" e2="DDI-PubMed.26123461.s3.e2" /></sentence><sentence text=" Clinical evaluation and laboratory findings excluded the presence of systemic diseases that might have been able to explain the drug inefficacy, while pharmacological evaluation suggested a possible drug-drug interaction" /><sentence text=" In order to assess the possible occurrence of resistance, mutational analysis of hepatitis B virus (HBV) was performed and excluded the presence of resistance for TDF"><entity charOffset="164-166" id="DDI-PubMed.26123461.s5.e0" text="TDF" /></sentence><sentence text=" TDF was prescribed, and venlafaxine, paroxetine and zolpidem were discontinued"><entity charOffset="25-36" id="DDI-PubMed.26123461.s6.e0" text="venlafaxine" /><entity charOffset="38-48" id="DDI-PubMed.26123461.s6.e1" text="paroxetine" /><entity charOffset="53-61" id="DDI-PubMed.26123461.s6.e2" text="zolpidem" /><entity charOffset="1-8" id="DDI-PubMed.26123461.s6.e3" text="TDF" /><pair ddi="false" e1="DDI-PubMed.26123461.s6.e3" e2="DDI-PubMed.26123461.s6.e3" /><pair ddi="false" e1="DDI-PubMed.26123461.s6.e3" e2="DDI-PubMed.26123461.s6.e0" /><pair ddi="false" e1="DDI-PubMed.26123461.s6.e3" e2="DDI-PubMed.26123461.s6.e1" /><pair ddi="false" e1="DDI-PubMed.26123461.s6.e3" e2="DDI-PubMed.26123461.s6.e2" /><pair ddi="false" e1="DDI-PubMed.26123461.s6.e0" e2="DDI-PubMed.26123461.s6.e0" /><pair ddi="false" e1="DDI-PubMed.26123461.s6.e0" e2="DDI-PubMed.26123461.s6.e1" /><pair ddi="false" e1="DDI-PubMed.26123461.s6.e0" e2="DDI-PubMed.26123461.s6.e2" /><pair ddi="false" e1="DDI-PubMed.26123461.s6.e1" e2="DDI-PubMed.26123461.s6.e1" /><pair ddi="false" e1="DDI-PubMed.26123461.s6.e1" e2="DDI-PubMed.26123461.s6.e2" /></sentence><sentence text=" The follow-up at 3, 6 and 12 months documented a good response to TDF with a time-related decrease of HBV-DNA and alanine aminotransferase"><entity charOffset="115-122" id="DDI-PubMed.26123461.s7.e0" text="alanine" /><entity charOffset="67-73" id="DDI-PubMed.26123461.s7.e1" text="TDF" /><pair ddi="false" e1="DDI-PubMed.26123461.s7.e1" e2="DDI-PubMed.26123461.s7.e1" /><pair ddi="false" e1="DDI-PubMed.26123461.s7.e1" e2="DDI-PubMed.26123461.s7.e0" /></sentence><sentence text="" /></document>